Vivoryon Therapeutics N.V.
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Profit margin reached 783%. Total operating expenses were $25,742,000.
Profit Margin
| 2014 | 0 | -11.43M | |
|---|---|---|---|
| 2015 | 0 | -13.50M | |
| 2016 | 0 | -13.89M | |
| 2017 | 0 | -8.00M | |
| 2018 | 0 | -7.73M | |
| 2019 | 0 | -7.82M | |
| 2020 | 0 | -16.51M | |
| 2021 | 10.76M | -12.65M | -117.57% |
| 2022 | 0 | -28.15M | |
| 2023 | -3.62M | -28.34M | 782.93% |
0R3M.L Income Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | -3.62M | 0 | 10.76M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cost of revenue | -525K | 161K | 1.73M | 146K | 88K | 23K | 106K | 97K | 56K | 0 |
Gross profit | -3.09M | -161K | 9.03M | -146K | -88K | -23K | -106K | -97K | -56K | 0 |
Operating exp. | ||||||||||
Research and development | 17.63M | 20.22M | 17.45M | 13.21M | 4.75M | 4.83M | 7.45M | 10.95M | 10.15M | 8.00M |
Selling and marketing | 3K | 8.73M | 4.37M | 2.65M | 2.93M | 2.86M | 2.40M | 2.80M | 3.21M | 0 |
Total operating expenses | 25.74M | 28.97M | 21.83M | 15.87M | 7.68M | 7.70M | 9.85M | 13.76M | 13.38M | 11.26M |
Operating income | -28.83M | -29.13M | -12.80M | -16.01M | -7.77M | -7.72M | -9.96M | -13.86M | -13.43M | -11.26M |
Other income (expenses), net | 261K | 777K | 583K | -493K | -49K | -10K | 854K | -31K | -68K | -170K |
Income before tax | -28.57M | -28.35M | -12.22M | -16.51M | -7.82M | -7.73M | -9.11M | -13.89M | -13.50M | -11.43M |
Income tax expense | -234K | -199K | 432K | 0 | 0 | 0 | -1.10M | 0 | 0 | 0 |
Net income | -28.34M | -28.15M | -12.65M | -16.51M | -7.82M | -7.73M | -8.00M | -13.89M | -13.50M | -11.43M |
Earnings per share | ||||||||||
Basic EPS | -1.12 | -1.28 | -0.63 | -0.83 | -0.62 | -0.92 | -0.96 | -1.79 | -1.93 | -2.35 |
Diluted EPS | -1.12 | -1.28 | -0.63 | -0.83 | -0.62 | -0.92 | -0.96 | -1.79 | -1.93 | -2.35 |